Phosphoramidon, a novel matrix metalloproteinase inhibitor, inhibits significantly tumor growth independently of the application route in a rat model of peritoneal carcinomatosis

被引：0
|
作者：
Hribaschek, A
Meyer, F
Ridwelski, K
Pross, M
Habermann, P
Halangk, W
Lippert, H
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A776 / A776
页数：1
相关论文
共 25 条
  • [21] A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer
    Ii, Hiromi
    Yoshiya, Taku
    Nakata, Susumu
    Taniguchi, Keiko
    Hidaka, Koushi
    Tsuda, Shugo
    Mochizuki, Masayoshi
    Nishiuchi, Yuji
    Tsuda, Yuko
    Ito, Kosei
    Kageyama, Susumu
    Yoshiki, Tatsuhiro
    CHEMMEDCHEM, 2018, 13 (02) : 155 - 163
  • [22] THE NOVEL c-MET INHIBITOR ALTIRATINIB (DCC-2701) INHIBITS TUMOR GROWTH AND INVASION IN A BEVACIZUMAB RESISTANT GLIOBLASTOMA MOUSE MODEL
    Piao, Yuji
    Smith, Bryan
    Thomas, Craig
    Holmes, Lindsay
    Henry, Verlene
    Flynn, Daniel L.
    de Groot, John
    NEURO-ONCOLOGY, 2014, 16
  • [23] CB-12181, a New Azasugar-Based Matrix Metalloproteinase/Tumor Necrosis Factor-α Converting Enzyme Inhibitor, Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and Retinal Neovascularization in Vivo
    Chikaraishi, Yuichi
    Shimazawa, Masamitsu
    Yokota, Koichi
    Yoshino, Koichiro
    Hara, Hideaki
    CURRENT NEUROVASCULAR RESEARCH, 2009, 6 (03) : 140 - 147
  • [24] The effects of tongdujianbu particle treatment on matrix metallopeptidase 9 (MMP-9), tissue inhibitor of metalloproteinase (TIMP)-1, and transformation growth factor (TGF)-β1 expression in a rat model of spinal core injury
    Luo, Yi
    Deng, Zhansheng
    Huang, Shu
    Wei, Mei
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (16): : 1231 - 1238
  • [25] VERU-111, A NOVEL ORAL INHIBITOR OF α AND β TUBULIN, INHIBITS TUMOR GROWTH IN THE HUMAN CASTRATION-RESISTANT AR VARIANT PROSTATE CANCER (PCA) MODEL 22RV1
    Getzenberg, Robert
    Markowski, Mark
    Steiner, Mitchell
    Eisenberger, Mario
    Antonarakis, Emmanuel
    JOURNAL OF UROLOGY, 2019, 201 (04): : E495 - E495
123